The study reviewed US medical claims databases from 2005 to 2021 and compared CVD outcomes in narcolepsy patients and ...

AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...

The link between narcolepsy and cardiovascular disease (CVD) was strengthened by new evidence that the relationship applied ...

From baseline, patients treated with AXS-12 had an 83% reduction in cataplexy attacks at the end of 5 weeks compared with a 66% reduction with placebo (rate ratio [RR] 0.49, P=0.0 ...

Some common narcolepsy comorbidities include obstructive sleep apnea (OSA), attention deficit hyperactivity disorder (ADHD), restless legs syndrome (RLS), anxiety, and depression. Comorbidities ...

Credit: fizkes via Shutterstock. Narcolepsy is a sleep disorder that specifically affects the rapid eye movement (REM) cycle. Hallmark symptoms of narcolepsy include excessive daytime sleepiness (EDS) ...

Narcolepsy is linked to adverse cardiovascular disease (CVD) outcomes, but few studies have examined its associations with subclinical CVD, including in children. We assessed the relationship between ...

USA: A retrospective cohort study using Medicare and commercial insurance data has found that narcolepsy is associated with ...

Narcolepsy is a condition causing patients to experience excessive sleepiness during the day and sleep disruption overnight. Dream sleep (Rapid Eye Movement sleep or REM sleep) phenomena occur at odd ...

Those who care about making America healthy need to be careful not to tie themselves so tightly to a man who never cared about actual science.